🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

'The folk who tend to miss the greatest number of appointments are the folk who have the largest number of long-term mental and physical health conditions' EXC Why fines are 'not the answer' to stop people missing GP appointments heraldscotland.com/news/24412352.… heraldscotland.com/news/24412352.…

Association of latent class analysis-derived #multimorbidity clusters with adverse #health outcomes. sciencedirect.com/science/articl… - Great to see this paper out from PERFORM Trial team @bhauteshjani UofG GPPC UofG MVLS

Living Longer But Frailer? Temporal Trends in Life Expectancy and Frailty in Older Swedish Adults academic.oup.com/biomedgerontol…

📝 Just published in Ageing Research Reviews: Frailty and socioeconomic position: A systematic review of observational studies. Great work of Peter Hanlon & Team. Elsa Dent Davide L Vetrano Marina Politis (she/her) caitlin jones Amsterdam Public Health research institute #OpenAccess #Frailty See: doi.org/10.1016/j.arr.…

This is a key recommendation from fantastic work by Peter Hanlon and team - supporting Sir Michael Marmot’s calls for “proportionate universalism” Premature frailty will be very familiar to all working in Deep End GP Scotland Emergency Medicine at the Deep End Deep End GP YH Deep End Canberra Deep End Ireland

Familiar issues for emergency medicine - services in more deprived areas face greater needs across the spectrum of illness. Echos a key point from David Chung 🦀 at our last meeting - age-based services poorly serve deprived areas, where early and multimorbidity frailty is common

Peter Hanlon This paper showed the extreme acceleration of this effect in a population in an extreme position of socio economic deprivation - people experiencing homelessness. Living in hostels that are woefully under-resourced to meet their residents needs. pathway.org.uk/resources/prem…

Our new paper, led by Dhan Senaratne, reports a dose-response relationship between Adverse Childhood Experiences and multimorbidity. Each ACE increased the odds by 13%. Chronic Pain Research Group Dundee University Bhushan Thakkar PT, PhD Dr. Louise Marryat Lesley Colvin UoD Medicine NRS Pain Research Community doi.org/10.1186/s12916…

Yey! Print version! Very chuffed - well done @woodford_henry Dan McKenzie and thank you The BMJ bmj.com/content/387/bm… ❤️🥳❤️🥳❤️🥳❤️🥳❤️🥳❤️

📣 We’re thrilled to announce the BGS Rising Star Award winners 2024! 📣 They are transforming healthcare for older people through innovation in research and clinical quality. 🏆 #BGSRisingStar bgs.org.uk/policy-and-med…

Thank you so much British Geriatrics Society for this #BGSRisingStar award! It’s a hugely exciting time to be doing research to better support people living with frailty and long-term conditions. Very grateful for the award, and to the many who have supported me to far.

Our new paper in JAMA on age and sex differences in efficacy of diabetes treatments. It shows that older age is associated with greater cardiovascular benefits of SGLT2 inhibitors despite smaller improvement in HbA1c compared to younger people. jamanetwork.com/journals/jama/…

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new University of Glasgow research which looked at data from more than 300,000 patients. UofG MVLS UofG School of Health & Wellbeing More ➡️ gla.ac/40YaaXJ jamanetwork.com/journals/jama/…

Network meta-analysis- 601 trials! SGLT2 inhibitors & GLP-1 receptor agonists associated with ⬇️ risk of MACE. SGLT2 inhibitors were more cardioprotective in older people GLP-1 receptor agonists more cardioprotective in younger people. jamanetwork.com/journals/jama/… Mamas A. Mamas

Does age or sex make a difference in how well newer glucose-lowering drugs work in patients with type 2 diabetes? SGLT2 inhibitors may be more effective in reducing cardiovascular events in older adults with type 2 diabetes. Read more: ja.ma/3Cqvk7z